V027-8329 Screening compound: 4-(4-methylpiperazin-1-yl)-2-({[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl}sulfanyl)-6-phenylpyrimidine

V027-8329 Screening compound: 4-(4-methylpiperazin-1-yl)-2-({[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl}sulfanyl)-6-phenylpyrimidine
V027-8329 Screening compound: 4-(4-methylpiperazin-1-yl)-2-({[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl}sulfanyl)-6-phenylpyrimidine alternative view

Chemical Structure Depiction of ChemDiv screening compound V027-8329
4-(4-methylpiperazin-1-yl)-2-({[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl}sulfanyl)-6-phenylpyrimidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V027-8329

Molecular Formula

C28H34N6OS (C28 H34 N6 OS)

Compound Name

4-(4-methylpiperazin-1-yl)-2-({[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl}sulfanyl)-6-phenylpyrimidine

IUPAC name

4-(4-methylpiperazin-1-yl)-2-({[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl}sulfanyl)-6-phenylpyrimidine

SMILES

CN(CC1)CCN1C(c1cccc(CSc2nc(N3CCN(C)CC3)cc(-c3ccccc3)n2)c1)=O

InChI

InChI=1S/C28H34N6OS/c1-31-11-15-33(16-12-31)26-20-25(23-8-4-3-5-9-23)29-28(30-26)36-21-22-7-6-10-24(19-22)27(35)34-17-13-32(2)14-18-34/h3-10,19-20H,11-18,21H2,1-2H3

InChI Key

MHZYWNSZKMVMCI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19818308

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

502.68

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.039

Distribution Coefficient, logD

3.469

Water Solubility, LogSw

-4.08

Polar Surface Area

43.506

Acid Dissociation Constant (pKa)

22.01

Base Dissociation Constant (pKb)

7.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.30

V027-8329 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS Targets (44014 compounds)

GABA Library (7115 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
  • Ion Channels
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V027-8329 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V027-8329?
Check Price and Availability of V027-8329, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V027-8329 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V027-8329
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V027-8329
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V027-8329 available by request